IDEAYA Biosciences, Inc.
NASDAQ:IDYA · NASDAQ Global Select
-$0.45 today
Vol 1.48M · Avg 1.44M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+45.80%
Period High
$37.86
Period Low
$21.02
Latest
$31.23
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Cogent Biosciences, Inc.
NASDAQ:COGT
$5.88B
Scholar Rock Holding Corporation
NASDAQ:SRRK
$5.63B
Cidara Therapeutics, Inc.
CDTX
$5.61B
Legend Biotech Corporation
NASDAQ:LEGN
$5.30B
Amicus Therapeutics, Inc.
FOLD
$4.55B
Kiniksa Pharmaceuticals, Ltd.
NASDAQ:KNSA
$4.13B
Beam Therapeutics Inc.
NASDAQ:BEAM
$3.40B
Adaptive Biotechnologies Corporation
NASDAQ:ADPT
$2.79B
Zai Lab Limited
NASDAQ:ZLAB
$2.09B
Mineralys Therapeutics, Inc.
NASDAQ:MLYS
$1.69B
What is the latest IDYA filing?
The latest filing shown is 8-K dated Jun 10, 2026.
How many recent filings does IDYA have?
Intrinsic Alpha currently shows 20 recent filings for IDYA.
Explore More
Continue the stock analysis
Jump to another research area for this company.